Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 27 min ago
PreprintCC BY-NC-NDbioRxiv

Angiogenin activity regulates RNA remodeling during the maternal-to-zygotic transition in early mouse embryogenesis

  1. 1Institute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, India-560065

Abstract

Angiogenin (ANG), a member of the RNase A superfamily, regulates multiple aspects of RNA metabolism, including rRNA processing and the generation of tRNA-derived small RNAs. However, its function during early mammalian embryogenesis remains unknown. Here, we identify a previously unrecognized requirement for ANG activity during early mouse embryonic development. Pharmacological inhibition of ANG during the first embryonic cell cycle did not prevent progression to the 2-cell stage but markedly impaired subsequent development to the 4-cell stage, indicating a critical requirement for ANG activity during the maternal-to-zygotic transition. Transcriptome-wide analysis revealed that ANG inhibition disrupted the normal remodeling of the embryonic transcriptome, characterized by persistent accumulation of a subset of transcripts that are normally reduced during the 2-cell transition, including many maternally deposited RNAs, together with altered expression of transcripts associated with zygotic genome activation. Small-RNA profiling further revealed widespread alterations in miRNA and tRNA-derived small-RNA populations. Notably, a large proportion of transcripts retained following ANG inhibition contained predicted target sites for miRNAs that were concomitantly reduced, suggesting a potential link between ANG-dependent small-RNA regulation and maternal transcript clearance. ANG inhibition was also associated with altered abundance and organization of components of RNA regulatory granules, including Tudor, TIAR, Dcp1a and Ago2, and increased association of selected retained transcripts Reep4 and Esrrb with Tudor-positive structures. Together, these findings identify ANG activity as an important regulator of RNA remodeling during the maternal-to-zygotic transition and suggest that ANG coordinates maternal transcript clearance, small-RNA dynamics and mRNP organization to support early mouse embryonic development.

Related

  1. RhoGEF Solo regulates cell density-dependent keratin remodeling and desmosome maturation
    U. Kawasaki, R. Maruta, K. Mizuno +2
    bioRxivPreprintAll rights reservedFull textCell biologybioRxiv
  2. Cell surface ribosomal RNA remodeling regulates hematopoietic stem cell trafficking
    N. Geng, M. Yang, X. Zeng +12
    bioRxivPreprintCC BYFull textCell biologybioRxiv
  3. The IFN-γ-inducible GTPase IIGP1 regulates mitochondrial remodeling and immunometabolic reprogramming during inflammatory macrophage polarization
    A. K. Singh, S. Sharma, K. Ahuja +4
    bioRxivPreprintCC BY-NC-NDFull textImmunologybioRxiv
  4. Remodeling of cholesterol metabolism in melanoma progression regulates nuclear membrane mechanics.
    M. A. Baird, D. A. Malide, C. A. Combs +2
    bioRxivPreprintCC0Full textCell biologybioRxiv
  5. Phosphorylation by CaMKIV regulates the transcriptional repressor activity and half-life of REST/NRSF
    Hanako Tsushima Semini, Beatrice Corradi, Caterina Canevari +10
    Science AdvancesPeer-reviewedCC BYFull textNeuroscienceCrossrefEurope PMC
BibTeX
@misc{sharma2026angiogenin,
  title = {{Angiogenin activity regulates RNA remodeling during the maternal-to-zygotic transition in early mouse embryogenesis}},
  author = {S. Sharma and N. Hariharan and A. S. Kurbet and P. K. Vemula and A. Jory and T. Mukherjee and D. Palakodeti},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.22.753398},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.22.753398v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Angiogenin activity regulates RNA remodeling during the maternal-to-zygotic transition in early mouse embryogenesis
AU  - S. Sharma
AU  - N. Hariharan
AU  - A. S. Kurbet
AU  - P. K. Vemula
AU  - A. Jory
AU  - T. Mukherjee
AU  - D. Palakodeti
PY  - 2026
DA  - 2026/09/22
PB  - bioRxiv
DO  - 10.64898/2026.09.22.753398
UR  - https://www.biorxiv.org/content/10.64898/2026.09.22.753398v1
AB  - Angiogenin (ANG), a member of the RNase A superfamily, regulates multiple aspects of RNA metabolism, including rRNA processing and the generation of tRNA-derived small RNAs. However, its function during early mammalian embryogenesis remains unknown. Here, we identify a previously unrecognized requirement for ANG activity during early mouse embryonic development. Pharmacological inhibition of ANG during the first embryonic cell cycle did not prevent progression to the 2-cell stage but markedly impaired subsequent development to the 4-cell stage, indicating a critical requirement for ANG activity during the maternal-to-zygotic transition. Transcriptome-wide analysis revealed that ANG inhibition disrupted the normal remodeling of the embryonic transcriptome, characterized by persistent accumulation of a subset of transcripts that are normally reduced during the 2-cell transition, including many maternally deposited RNAs, together with altered expression of transcripts associated with zygotic genome activation. Small-RNA profiling further revealed widespread alterations in miRNA and tRNA-derived small-RNA populations. Notably, a large proportion of transcripts retained following ANG inhibition contained predicted target sites for miRNAs that were concomitantly reduced, suggesting a potential link between ANG-dependent small-RNA regulation and maternal transcript clearance. ANG inhibition was also associated with altered abundance and organization of components of RNA regulatory granules, including Tudor, TIAR, Dcp1a and Ago2, and increased association of selected retained transcripts Reep4 and Esrrb with Tudor-positive structures. Together, these findings identify ANG activity as an important regulator of RNA remodeling during the maternal-to-zygotic transition and suggest that ANG coordinates maternal transcript clearance, small-RNA dynamics and mRNP organization to support early mouse embryonic development.
ER  -